Physician profile
Mohamed Hakim
NPI 1316383979
$51,502.62
in general payments reported to CMS, 2019-2025
9 companies · $738 in 2025
The $738 reported for 2025 was more than what 83% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,500 · 2020: $23K · 2021: $808 · 2022: $11K · 2023: $9,177 · 2024: $68.48 · 2025: $738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,360 · Consulting Fee: $4,000 · Food and Beverage: $1,624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,359.89 |
| Consulting Fee | $4,000.00 |
| Food and Beverage | $1,623.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $30,000.00 | 2019-2020 | |
| Nexus Cmf, LLC | $20,640.30 | 2021-2023 | Mccain Arthroscopy System |
| Stryker Corporation | $448.69 | 2023-2025 | Patient-Fitted Tmj Reconstructive Prosthesis System, Vsp System, Vsp Cranial |
| Zimvie INC. | $170.21 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $124.95 | 2025 | |
| Geistlich Pharma, North America, INC. | $37.55 | 2024 | Geistlich Bio-Gide |
| Align Technology, INC. | $32.64 | 2025 | Invisalign |
| Depuy Synthes Sales INC. | $30.93 | 2024 | Na, Trumatch |
| Pacira Pharmaceuticals Incorporated | $17.35 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Hakim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.